7 Posts Not to Miss From the EHA 2025 – Nico Gagelmann
The European Hematology Association (EHA) 2025 events bring together global experts to explore the latest advances in hematology. This year features two major gatherings: the EHA Research Conference (March 17–20 in Málaga, Spain), focusing on transcriptional control and chromatin in hematopoiesis, and the 30th EHA Annual Congress (June 12–15 in Milan, Italy), a hybrid event showcasing cutting-edge research, clinical updates, and educational sessions.
EHA 2025 offers a unique platform for knowledge exchange, collaboration, and innovation in blood disorders and research.
Nico Gagelmann, Young National Society Ambassador at European Hematology Association (EHA) and Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared following posts from EHA 2025 on X:
1. “The best way to learn is from and with different generations.”
2. “Friends make medicine, science and life better, better together”
3. “Amazing session at EHA2025 with Coleman Lindsley and Mike Spencer Chapman chaired by Anna Sureda on
– Donor selection in families with recurreny myeloid mutations / Donor clonal hematopoiesis and recipient outcomes after transplantation
– Philogenetics of donor derived hematopoiesis”
4. “Fresh start with Clonal Hematopoiesis at last day of EHA2025 with Mikko Myllymäki”
5. “Excellent presentation by Carmelo Gurnari on the clinico genomic features of therapy-related myeloid neoplasm in EHA2025.”
6. “Fascinating European Hematology Association and The EBMT session at EHA2025 chaired by
Anna Sureda and Konstanze Döhner covering
New strategies for mismatched SCT (advances in donor selection and immunosuppression) by F Ciceri
The role of CAR-T as bridging to SCT (CAR-T vs SCT, or CAR-T and SCT?) by MariSubklewe
Outpatient CAR-T by Alexandra Martínez-Roca”
7. “Amazing Young EHA session at EHA2025 on critical appraisal of trialsSurrogates by Come Bommier.
Trial interpretation Eddie Cliff
And much more giving food for brain.”
Find more posts featuring EHA 2025 on Hemostasis Today.
-
Apr 5, 2026, 19:00Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients
-
Apr 5, 2026, 18:22Omar Adwan: Systematic Approach to Blood Smear Examination
-
Apr 5, 2026, 18:05Heghine Khachatryan: Rethinking Hemostatic Targets in Pregnancy for von Willebrand Disease
-
Apr 5, 2026, 17:45Matthew Walls: Recognising CAD PRS as a New ‘Risk Enhancing Factor’ in the 2026 ACC/AHA Guidelines
-
Apr 5, 2026, 17:44Philip A. Chan: Occasional Heavy Drinking Leads to 3 Times Higher Liver Fibrosis Risk in MASLD
-
Apr 5, 2026, 17:42Josu de la Fuente: Real World Data Shows Significant Risk of Subsequent HCT in SCD and Thalassemia
-
Apr 5, 2026, 17:41Gevorg Yaghjyan: Attending an AI Conference on AI in Clinical Medicine, Research and Education
-
Apr 5, 2026, 17:41Ifeanyichukwu Ifechidere: The Mastermind of Clotting – A Thrombin Story
-
Apr 5, 2026, 17:38Thomas Ichim: Making iPSC Cells from Menstrual Blood Stem Cells